Sustanon 250mg/ml 10ml Vial by Kim Pharma

Usage

1. Confirm your contest timeline: map injection dates against your competition calendar, targeting final administration no later than 5–7 days before show day to allow the short esters to clear while the decanoate fraction maintains residual coverage.
2. Draw your prep-phase dose using a 1ml graduated syringe — at 250mg/ml, each 0.1ml graduation equals 25mg, enabling 62.5mg precision increments without estimation.
3. Warm the 10ml vial briefly in the palm of your hand for 30–60 seconds if oil viscosity makes drawing slow; this reduces aspiration time and minimises air bubble formation in the syringe.
4. Inject intramuscularly into the glute or lateral quad using a 23–25g 1-inch needle; rotate injection sites across twice-weekly administrations to avoid localised scar tissue accumulation across a 10–12 week prep.
5. Log each draw date, volume, and injection site in a prep diary — the 10ml vial's multi-dose format makes it easy to lose track of cumulative dose without a written record during cognitively demanding contest prep.
6. Store the open vial at room temperature (15–25°C), away from direct light; do not refrigerate an opened oil-based injectable as this increases viscosity and risks draw-volume inaccuracy on subsequent uses.

Warnings

Frequently asked questions

How should Sustanon 250mg/ml dosing be adjusted during the final weeks of contest prep?

During the final 8–12 weeks before competition, most athletes taper Sustanon weekly dose from 500mg down to 250–375mg to minimise aromatisation-driven water retention while retaining lean tissue. Kim Pharma's 10ml vial allows 62.5mg per 0.25ml draw, making incremental weekly reductions straightforward without wasting product or opening additional vials.

When in a contest-prep cycle should athletes transition from a higher testosterone dose to a maintenance dose?

The transition to a maintenance dose — typically 250mg/week or lower — is generally initiated 6–8 weeks out from the competition date. This window allows the decanoate fraction in Sustanon 250mg/ml to taper naturally into the final prep phase while the shorter esters maintain near-daily androgenic coverage, avoiding abrupt hormonal drops that can compromise training performance.

What weekly dose of Sustanon 250mg/ml is considered standard for a natural testosterone maintenance baseline during competition prep?

A dose of 250–375mg per week — one to one-and-a-half 1ml draws from Kim Pharma's 10ml vial — is widely referenced as a contest-prep maintenance range. This quantity supports muscle fullness and androgen receptor occupancy without the estrogen load associated with off-season doses above 500mg/week, as documented in clinical testosterone dose-response literature.

How many doses does Kim Pharma's 10ml Sustanon vial provide, and how does this benefit precision contest dosing?

A 10ml vial at 250mg/ml contains 2,500mg total testosterone across all four esters. At a twice-weekly 0.5ml injection schedule (125mg per shot, 250mg/week), the vial supplies ten full weeks of dosing — covering the entire final contest-prep phase from a single point-of-purchase, reducing supply interruptions common with smaller-format ampoules.

Does the 250mg/ml concentration in Kim Pharma Sustanon offer any practical advantage compared to higher-concentration testosterone blends during cutting phases?

Yes — 250mg/ml represents the lowest standard concentration in the testosterone blend category, which means injection volume is larger per milligram, making sub-1ml draws for low-dose contest protocols easier to measure accurately with a standard 1ml syringe. Higher-concentration blends (e.g. 400mg/ml or 500mg/ml) compress the volume so tightly that small measurement errors translate into proportionally larger dose deviations — a risk that matters most during the precision-critical weeks before a competition.

Manufacturer

Kim Pharma's market standing in the competitive injectable testosterone segment is built on a straightforward value proposition: analytical verification at the batch level, not as a premium add-on. In a product category where brand differentiation is frequently claimed but rarely substantiated, Kim Pharma has positioned itself as a volume-accessible, documentation-backed supplier — a combination that resonates specifically with structured-cycle athletes who require consistent label accuracy across multiple vials purchased over a 10–12 week contest-prep period. The brand's reputation among competition-oriented buyers is reinforced by its multi-dose 10ml vial format, which aligns per-vial economics with the supply volumes that contest prep actually demands, rather than requiring athletes to purchase multiple smaller-format units to cover a full cycle. Kim Pharma's market credibility is further anchored by its GMP-certified production environment and publicly communicable batch release documentation — HPLC potency confirmation and LAL endotoxin certificates — that allow end-users to cross-reference label claims against verifiable analytical data. This transparency-first market approach differentiates Kim Pharma from brands that compete on price alone, placing it in the mid-market tier where quality assurance and cost accessibility intersect.